Concert Pharmaceuticals Inc CNCE Financial and Strategic SWOT Analysis Review [Report Updated: 14032018] Prices from USD $125

02:18 EDT 26 Mar 2018 | BioPortfolio Reports

Concert Pharmaceuticals Inc CNCE Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Concert Pharmaceuticals Inc Concert Pharmaceuticals is a clinical stage biotechnology company which discovers and develops small molecule drugs. The company develops its products using its deuterated chemical entity DCE platform to develop novel therapeutics for autoimmune and inflammatory diseases, pulmonary diseases, and disorders of central nervous system CNS. Its product pipeline includes CTP543 deuterated ruxolitinib for alopecia areata; AVP786 deuterated dextromethorphan indicated for alzheimer's agitation, major depressive disorder and residual schizophrenia; CTP730 deuterated apremilast for inflammatory diseases; CTP692, a selective DCE modified analog of the endogenous amino acid, Dserine for Schizophrenia, and JZP386 deuterated sodiumoxybate for narcolepsy. It employs its deuterated compounds to reduce the extent of metabolism in the wall of the intestines and in the liver. Concert Pharmaceuticals is headquartered in Lexington, Massachusetts, the US.

Concert Pharmaceuticals Inc Key Recent Developments

Mar 01,2018: Concert Pharmaceuticals Reports Year Ended 2017 Financial Results

Jan 12,2018: Concert Pharmaceuticals Announces Patent Trial and Appeal Board Did Not Institute PGR Proceeding

Dec 18,2017: Concert Pharmaceuticals Announces the Appointment of Marc Becker as Chief Financial Officer

Dec 13,2017: Concert Pharmaceuticals to Be Added to NASDAQ Biotechnology Index

Nov 09,2017: Concert Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Company Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Concert Pharmaceuticals Inc CNCE Financial and Strategic SWOT Analysis Review [Report Updated: 14032018] Prices from USD $125


More From BioPortfolio on "Concert Pharmaceuticals Inc CNCE Financial and Strategic SWOT Analysis Review [Report Updated: 14032018] Prices from USD $125"

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...